Clinical Trials
58 trialsParaSOL
Guy's and St Thomas' NHS Foundation Trust
TPVB
Ciusss de L'Est de l'Île de Montréal
Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
FLICOR
Imperial College London
Depo-Trigger
Universitair Ziekenhuis Brussel
Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma
Fujian Medical University Union Hospital
Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study
Sun Yat-sen University
Clinical Study of Safety and Tolerability of Melphalan Hydrochloride for R/R MM
Peking University People's Hospital
GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors
Second Affiliated Hospital of Soochow University
Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors
North China Petroleum Bureau General Hospital
Study of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLC
Jiangsu Cancer Institute & Hospital
COSEFDIP
Xijing Hospital
A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer
Sun Yat-sen University
POLA
Medical University of Lublin
Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma
Zhongda Hospital
A Study to Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer
Fujian Medical University
Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy
Tianjin Medical University Cancer Institute and Hospital
Luscid
Universitair Ziekenhuis Brussel
A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
TIL
Fudan University
Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy
Women's Hospital School Of Medicine Zhejiang University
To Explore the Safety and Efficacy of Intravenous Infusion of Different Doses of Lidocaine in Patients
West China Hospital
FOCUS
Martin-Luther-Universität Halle-Wittenberg
Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD)
Seoul National University Hospital
ICGMFITinPLC
Zhujiang Hospital
The Value of Lymph Node Dissection of Indocyanine Green-guided Near-infrared Fluorescent Imaging in Esophagectomy
Fujian Medical University Union Hospital
Camrelizumab in Combination With Neoadjuvant Chemotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma
Zhejiang Cancer Hospital
Study of Oncolytic Virus in Combination With HX-008 and Axitinib in Melanoma Patients With Liver Metastasis
Peking University Cancer Hospital & Institute
Study of Oncolytic Virus in Combination With HX-008 and Radiotherapy in Melanoma Patients With Liver Metastasis
Peking University Cancer Hospital & Institute
Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma
Zhejiang Cancer Hospital
Brentuximab Vedotin in Combination With CHEP in Patient With PTCL
Czech Lymphoma Study Group
PRISME
Assistance Publique - Hôpitaux de Paris
A Prospective Multi-center Study on Using Sonazoid Diagnose Early Stage Endometrial Cancer
Chinese PLA General Hospital
A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC
Tang-Du Hospital
Sentinel Lymph Node Navigation Surgery Using Near-infrared Imaging in Early Esophageal Cancer
Fifth Affiliated Hospital, Sun Yat-Sen University
An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer
Chinese PLA General Hospital
Anti-PD-1 Antibody in the Treatment of Patients With Malignant Melanoma of the Female Genital Tract
Fudan University
The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in Oligometastatic Gastrointestinal Cancer
Fudan University
The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer
Fudan University
A Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma
Shanghai Junshi Bioscience Co., Ltd.
Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation
Ruijin Hospital
JS001 Combined With Regorafenib in Patients With Advanced Colorectal Cancer
Sun Yat-sen University
Efficacy and Safety of Camrelizumab for Injection, Apatinib Mesylate and Tegio for First-line Refractory Patients With Advanced Gastric Cancer
Beijing Friendship Hospital
Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer
Fujian Medical University
Compass-001
Sun Yat-sen University
Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC
Fuzhou General Hospital
A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC
Chinese PLA General Hospital
OC-01
Huazhong University of Science and Technology
Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression
Fudan University